[1] Blanchon T,Bréchot JM,Grenier PA,et al.Baseline results of the Depiscan study:a French randomized pilot trial of lung cancer screening comparing low dose ct scan(LDCT) and chest x-ray(CXR)[J].Lung Cancer,2007,58(1):50-58.
[2] Infante MV,Pedersen JH.Screening for lung cancer:are we there yet?[J].Curr Opin Pulm Med,2010,16(4):301-306.
[3] Menezes RJ,Roberts HC,Paul NS,et al.Lung cancer screening using low-dose computed tomography in at-risk individuals:the Toronto experience[J].Lung Cancer,2010,67(2):177-183.
[4] Vansteenkiste J,Dooms C,Mascaux C,et al.screening and early detection of lung cancer[J].Annals of Oncology,2012,23(Suppl10):x320-327.
[5] 吴宝英. 螺旋CT与高分辨CT用于直径<3cm周围型肺癌诊断结果对比与分析[J].中国医药导报,2011,12(24):78-79.
[6] Seemann MD,Staebler A,Beinert T,et al.Usefulness of morphological characteristics for the differentiation of benign from malignant solitary pulmonary lesions using HRCT[J].Eur Radiol,1999,9(3):409-417.
[7] Uhrmeister P,Allmann KH,Wertzel H,et al.Chest wall infiltration by lung cancer:value of thin-sectional ct with different reconstruction algorithms[J].Eur Radiol,1999,9(7):1304-1309.
[8] Fischer BM,Mortensen J,Langer SW,et al.A prospective study of PET/CT in initial staging of small-cell lung cancer:comparison with CT,bone scintigraphy and bone marrow analysis[J].Ann Oncol,2007,18(22):338-345.
[9] Mattar EH.Integrated PET/CT in imaging of non-small cell lung cancer[J].Journal of the Egyptian National Cancer Institute,2008,19(4):263-274.
[10] 廖日强,杨学宁,王思云,等.PET/CT鉴别肺癌中胸腔积液性质的临床价值[J].中国肺癌杂志,2012,15(11):652-655.
[11] 李斌,周海中,曹剑霞.SCC-Ag、CA19-9、CEA在肺癌患者血清中的变化及临床意义[J].放射免疫学杂志,2007,20(5):464-466.
[12] ZHU H,GUO HB,LI MH,et al.Increased serum carcinoembryonic antigen level can predict poor survival of patients with small cell lung cancer[J].Translational Research,2015,166(4):355-355.
[13] Tomita M,Ayabe T,Chosa E,et al.Correlation between Serum Carcinoembryonic Antigen Level and Histologic Subtype in Resected Lung Adenocarcinoma[J].Asian Pacific Journal of Cancer Prevention,2015,16(9):3857-3860.
[14] Huang CC,Zhan TC,Liu YM,et al.Glycomic profiling of carcinoembryonic antigen isolated from human tumor tissue[J].Clinical Proteomics,2015,12(1):1-7.
[15] Lou E,Johnson M,Sima C,et al.Serum biomarkers for assessing histology and outcomes in patients with metastatic lung outcomes in patients with metastatic lung[J].Cancer Biomarkers,2014,14(4):207-214.
[16] Ma L,Xie XW,Wang HY,et al.Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China[J].Asian Pacific Journal of Cancer Prevention,2015,16(12):4891-4894.
[17] Petrovic M,Bukumiric Z,Zdravkovic V,et al.The prognostic significance of the circulating neuroendocrine markers chromogranin A,pro-gastrin-releasing peptide,and neuron-specific enolase in patients with small-cell lung cancer[J].Med Oncol,2014,31(2):823-823.
[18] Emin Erbaycu A,Gunduz A,Batum O,et al.Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer:an open prospective study[J].Arch Bronconeumol,2010,46(7):364-369.
[19] Oremek G,Sauer-E,Bruzdziak TH.value of tumour and inflammatory markers in lung cancer.Anticancer Research,2007,27(4A):1911-1915.
[20] 何小帆,江明凤,金赛燕.多种肿瘤标志物联合检测的肺癌早期诊断价值[J].浙江预防医学,2014,26(7):750-756.
[21] 彭保成,刘斌,孙长录,等.影像学检查联合NSE、SCC-Ag、Cyfra21-1检测对肺癌诊断的临床价值[J].中国医药指南,2012,10(13):163-164.
[22] 甄永生,蒙志宏,靳强,等.周围型肺癌CT表现及与血清肿瘤标志物CYFRA21-1的相关性研究[J].河北医药,2014,11(36):3404-3406.
[23] 谭理连,周洁,李志铭,等.周围型肺癌病理CT表现与血清肿瘤标志物CEA关系研究[J].中国临床医学影像学杂志,2011,22(7):464-467. |
